Donoghue Forlines’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,192
| Closed | -$272K | – | 257 |
|
|
2023
Q2 | $272K | Buy |
+2,192
| New | +$272K | 0.09% | 231 |
|
|
2023
Q1 | – | Sell |
-9,875
| Closed | -$1.57M | – | 240 |
|
|
2022
Q4 | $1.57M | Buy |
9,875
+8,356
| +550% | +$1.33M | 0.56% | 37 |
|
|
2022
Q3 | $202K | Sell |
1,519
-2,675
| -64% | -$356K | 0.07% | 231 |
|
|
2022
Q2 | $654K | Buy |
+4,194
| New | +$654K | 0.17% | 151 |
|
|
2021
Q3 | – | Sell |
-3,792
| Closed | -$674K | – | 222 |
|
|
2021
Q2 | $674K | Sell |
3,792
-23
| -0.6% | -$4.09K | 0.13% | 166 |
|
|
2021
Q1 | $627K | Sell |
3,815
-569
| -13% | -$93.5K | 0.12% | 170 |
|
|
2020
Q4 | $724K | Buy |
+4,384
| New | +$724K | 0.14% | 177 |
|